| SHZAMSTOCKS' FEATURED PROFILES |
|
| FREE
STOCK PICKS IN YOUR EMAIL |
|
|
PROFILES
Welcome to our comprehensive profile on Positron Corp.
(OTCBB: POSC)
|
MANAGEMENT
Patrick G. Rooney
Chairman of the Board
Mr. Rooney has served as Chairman of the Company since July 26, 2004. Mr. Rooney is the Managing Director of Solaris Opportunity Fund L.P., an investing/trading hedge fund. Through years 1985-2000, Patrick G. Rooney and/or Rooney Trading was a member of The Chicago Board of Options Exchange, The Chicago Board of Trade and The Chicago Mercantile Exchange. In September 1998 through March 2003, Mr. Rooney managed Digital Age Ventures, Ltd., a venture capital investment company.
Joseph G. Oliverio
President & Director
Mr. Oliverio was appointed by the Board of Directors to serve as the Company's President on December 21, 2005 Mr. Oliverio has been involved with Positron Corporation since 1995 working as a nuclear medicine technologist in a large cardiology group in Buffalo, NY, and assistant service engineer. Mr. Oliverio has performed more than 13,000 combined heart and cancer PET scans. Oliverio brings to Positron a valuable combination of clinical, technical and business skill sets. Prior to accepting the President position, Mr. Oliverio was Chief Operating Officer of Michael E. Merhige, M.D., LLC, a Coronary Disease Reversal and Prevention Center operating within Niagara Falls Memorial Medical Center.
Timothy M. Gabel
Vice President of Operations
Mr. Gabel, Vice President of Operations for Positron Corporation since March of 2006. Prior hereto and from 1996, Mr. Gabel specialized in international business, international technical project management, product research and development, lean manufacturing implementation, and product design with the automotive components supplier, Delphi Corporation. His experience includes technology transfer and joint venture partnership development with companies in China, Japan, Mexico and Europe. Mr. Gabel holds four U.S. patents, and earned his Bachelor’s of Science in Mechanical Engineering from the State University of New York at Buffalo.
Corey N. Conn
Chief Financial Officer & Director
Mr. Conn was appointed by the Board of Directors to serve as Chief Financial Officer on October 27, 2005. Mr. Conn brings over 15 years of experience in developing and managing information services companies. Mr. Conn currently is President of IMAGIN Molecular Corporation, a holding company whose focus is developing and acquiring equity positions in companies associated with Medical Imaging. Mr. Conn was Vice President of Business Development at iXL, an e-business and e‑transformations services provider from 1995 - 1999 and also served as Managing Director of Virtual Partnerships, LLC, a business development and business strategy consulting firm from 1999 - 2004.
John Zehner
President, Positron Pharmaceuticals
Mr. Zehner
has over 14 years of experience in the Nuclear Medicine field. John has been part of several start-ups, mergers and acquisitions. In 1993, he assisted in the start-up of Northern Virginia Isotopes, Inc., a nuclear pharmacy focused on distributing radioactive pharmaceuticals for diagnostics and therapy to the Washington D.C. market. In 1994, he established Valley Isotopes, Inc., a nuclear pharmacy in Winchester, Virginia, Inc. In 1995, John led the formation of Eastern Isotopes, Inc. through the merger of three nuclear pharmacies and later established its pharmaceutical manufacturing division for FDG in 1998. In 1999, he became President and COO of Eastern Isotopes, Inc. and under his leadership grew sales from approximately $4 million to over $34 million by 2003. In 2004, Mr. Zehner led the extremely lucrative sale of Eastern Isotopes, Inc. to IBA, SA, a Belgium life science company.
Joseph C. Sardano
Director
Mr. Sardano served as a Senior Vice President of Sales and Marketing at Siemens Medical Solutions and CTI Molecular Imaging before becoming a strategic industry consultant and serving on the board of directors of various medical imaging companies. Mr. Sardano has served as CTI’s Senior Vice President of Sales and Marketing since September 2004. In this capacity, he lead the sales and marketing activities for all business units of CTI, including the sales of scanners under the sales agency agreement with Siemens Medical Solutions USA, Inc. Previously, Mr. Sardano served as Vice President of Sales for CTI Solutions from September 2002 to September 2004. Prior to joining CTI, Mr. Sardano held several key positions in the medical industry. He was with GE Medical Systems where he served as Region Sales Manager from 1999 to 2000 and as P.E.T. Americas Sales Manager from 2001 to 2002. Prior to that, Mr. Sardano served as Vice President Sales for Elscint Inc., and Vice President and General Sales Manager for Fisher Scientific. He has also served in various management capacities with Toshiba America Medical Systems, Medstone International and Xerox Corporation. Mr. Sardano holds a Bachelor of Arts degree from Concordia University in Montreal, Canada and an Executive Business Development Diploma from McGill University.
Sachio Okamura
Director
Mr. Okamura has served as a director since his appointment to the Board of the Company on April 1, 2001. Mr. Okamura has performed bio-medical consulting services for Okamura Associates, Inc. from 1993 through the present date. These consulting services have included regulatory, distribution, licensing, joint venture, investment, merger and acquisition activities involving businesses in the United States and Japan. Mr. Okamura was in charge of bio-medical business development for various offices of Mitsubishi Corporation from 1978 through 1993. Mr. Okamura received a BS in Biochemistry in 1975 from the University of California, Davis and a Master of International Business from the American Graduate School of International Management in 1978.
Dr. Anthony C. Nicholls
Director
Dr. Nicholls is an independent consultant with over 30 years experience in medical devices and diagnostics research. He has lectured in 45 countries of the world on subjects varying from the rapid diagnosis of Sepsis, Tuberculosis and Aids to vaccine production, environmental responsibility and entrepreneurship. He co-founded FAS Medical Ltd., and as CEO, raised (CDN) $6 million, achieved a listing on CDNX and established sales of the company's products in 21 countries. Previously he was CEO of Trinity Biotech PLC and oversaw a successful IPO on NASDAQ. Earlier, Dr. Nicholls held senior management posts with Cambridge Biotech Corp. (Exec. VP), Biotech Research Labs Inc. (Pres. & COO), Fisher Scientific (Senior VP. & Gen. Manager), Ciba Corning Medical (Director, New Technology Development) and Flow General (International Scientific Director). Dr. Nicholls' academic career included seven years as Head of Microbiology and Immunology at the Midhurst Medical Research Institute in Sussex, England, where he published numerous papers on tuberculosis, pneumonia and sepsis.
David Bristow
Mr. Bristow has been part of the Positron development process of the Posicam HZ and HZL scanners since 1991 and has contributed to all aspects of the detector system, front end electronics system design, data acquisition system, real time operating system, commercialization, and characterization. Mr. Bristow is listed as one of the inventors on Patent 5,210,420 Positron emission tomography scanner. He has executed the most critical parts in the Posicam mPower design, technology transfer to the Neusoft Positron Corporation JV and developed an updated front end electronics system for the Attrius™,. Mr. Bristow earned a Bachelor of Science in Electrical Engineering degree and a Master of Science degree from Rice University in Houston, TX.
Imaging PET Technologies
Yuri Perevalov, PhD, Dr. Sc.
Vice-President of Strategy and Business Development of Imaging PET Technologies
Dr. Perevalov held different positions in financial analysis and planning in affiliated companies. Previously, Dr. Perevalov was Executive Vice-President of Research of an economic think-tank of the Russian Academy of Sciences (Ural Branch). Dr. Perevalov holds a BS from the Ural State Technical University and both a Candidate of Science (Economics) degree (PhD equivalent) and a Doctor of Science (Economics) degree from the Russian Academy of Sciences.
Professor Valeri Saveliev, PhD, Dr. Sc.
Chief Scientific Officer, Radiation Detectors, of IPT
Prof. Saveliev is one of the original co-inventors of the low-cost high-gain compact solid-state photo detectors capable of replacing photomultiplier tubes. Dr. Saveliev has developed computer codes that predict the electrical performance of photo-detector devices that are used to design and test the devices at each fabrication step. Dr. Saveliev is in charge of the development and commercialization of their solid-state advanced detection systems and materials. Prof. Saveliev holds a BS degree, a Candidate of Science degree (PhD equivalent) and a Doctor of Science degree (both in Physics and Mathematics) from the Moscow Engineering and Physics Institute.
The Company believes that its new management team has the tools and experience to lead the restructuring and diversification of its business. The Company is in the process of recruiting additional experienced individuals to augment its management team. There can be no assurance that the Company will be able to hire and retain a sufficient number of qualified personnel. |
|
